Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Net Income: 2013-2024

Historic Net Income for Aclaris Therapeutics (ACRS) over the last 12 years, with Dec 2024 value amounting to -$132.1 million.

  • Aclaris Therapeutics' Net Income fell 80.78% to -$15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$145.2 million, marking a year-over-year decrease of 279.49%. This contributed to the annual value of -$132.1 million for FY2024, which is 49.26% down from last year.
  • According to the latest figures from FY2024, Aclaris Therapeutics' Net Income is -$132.1 million, which was down 49.26% from -$88.5 million recorded in FY2023.
  • In the past 5 years, Aclaris Therapeutics' Net Income registered a high of $139,000 during FY2020, and its lowest value of -$132.1 million during FY2024.
  • In the last 3 years, Aclaris Therapeutics' Net Income had a median value of -$88.5 million in 2023 and averaged -$102.5 million.
  • Per our database at Business Quant, Aclaris Therapeutics' Net Income spiked by 100.29% in 2020 and then slumped by 65,470.50% in 2021.
  • Over the past 5 years, Aclaris Therapeutics' Net Income (Yearly) stood at $139,000 in 2020, then tumbled by 65,470.50% to -$90.9 million in 2021, then climbed by 4.35% to -$86.9 million in 2022, then decreased by 1.81% to -$88.5 million in 2023, then plummeted by 49.26% to -$132.1 million in 2024.